About Global Clinical Trials
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Merz Pharmaceuticals GmbH
2
Pfizer
2
BioNTech SE
1
Clover Biopharmaceuticals AUS Pty Ltd
1
Gilead Sciences
1
NEAT ID Foundation
1
PTC Therapeutics
1
Regeneron Pharmaceuticals
1
Sinovac Research and Development Co., Ltd.
1
Clinical Trials at Global Clinical Trials
During the past decade, Global Clinical Trials conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
2008-11-01
2010-06-01
Completed
400
Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
2009-01-01
2011-12-01
Terminated
821
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Global Clinical Trials" #1 sponsor was "Merz Pharmaceuticals GmbH" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "BioNTech SE" with 1 trials sponsored, "Clover Biopharmaceuticals AUS Pty Ltd" with 1 trials sponsored and "Gilead Sciences"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Global Clinical Trials"
#1 collaborator was "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Global Clinical Trials
According to Clinical.Site data, the most researched conditions in "Global Clinical Trials" are
"COVID-19" (6 trials), "SARS-CoV2 Infection" (2 trials), "Subjective Tinnitus" (2 trials), "Coronavirus" (1 trials) and "Coronavirus Infection" (1 trials). Many other conditions were trialed in "Global Clinical Trials" in a lesser frequency.
Clinical Trials Intervention Types at Global Clinical Trials
Most popular intervention types in "Global Clinical Trials" are "Drug" (7 trials), "Biological" (4 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Neramexane mesylate" (2 trials), "BNT162b2" (1 trials), "BNT162b2 (B.1.1.529)" (1 trials) and "BNT162b2 (B.1.1.7 + B.1.617.2)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Global Clinical Trials
The vast majority of trials in "Global Clinical Trials" are
11 trials for "All" genders.
Clinical Trials Status at Global Clinical Trials
Currently, there are NaN active trials in "Global Clinical Trials".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Global Clinical Trials,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Global Clinical Trials, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".